Escitalopram in Treating Depression in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Escitalopram in Treating Depression in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

This study is currently recruiting participants.

Study NCT00387348 Information provided by National Cancer Institute (NCI)

First Received: October 12, 2006 Last Updated: July 14, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Depression
Fatigue
Lung Cancer

Additional conditions recognized in this trial

Carcinoma, Non-Small-Cell Lung
Depressive Disorder
Lung Neoplasms

More general conditions related to this trial

Behavioral Symptoms
Carcinoma
Lung Diseases
Mental Disorders
Mood Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Signs and Symptoms
Thoracic Neoplasms

Interventions listed in this trial

escitalopram oxalate
fatigue assessment and management
management of therapy complications
quality-of-life assessment

Additional drug interventions recognized in this trial

Citalopram
Dexetimide

Sponsors listed in this trial

Massachusetts General Hospital
National Cancer Institute (NCI)

Back to top of Main Content